search
Back to results

Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris

Primary Purpose

Acne Vulgaris

Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
25% TRICHLOROACETIC ACID
30% salicylic acid
Sponsored by
Combined Military Hospital Abbottabad
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acne Vulgaris

Eligibility Criteria

13 Years - 22 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Patients with mild or moderate facial acne vulgaris presented in dermatology opd Exclusion Criteria: Patients with grade III or IV acne vulgaris patients taking any acne medications or had taken oral or topical medications in the past 4 weeks pregnant female patients or nursing a baby patients with known hypersensitivity to the formulations used in the study or a history of photosensitivity hypertrophic scars, keloidal tendency, active or recurrent herpes simplex infection active dermatosis unrealistic expectations

Sites / Locations

  • Cmh abbottabad

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Group A 25% TCA

Group B 30% SALICYLIC ACID

Arm Description

25% TCA peel Patients of group A were treated with 25% TCA peel and patients at 2-week intervals for a total of 12 weeks. Clinical evaluation was done at the end of therapy after 12-weeks of treatment.

30% SA peels Patients of group B were treated with 30 % salicylic acid peel and patients at 2 weeks interval for a total of 12 weeks.clinical evaluation was done at the end of therapy after 12 weeks of treatment

Outcomes

Primary Outcome Measures

Effectiveness of 25 % trichloroacetic acid peel versus 30 % salicylic acid peel in the treatment of mild to moderate acne vulgaris
Michaelson acne scores (MAS) Michaelson acne scores (MAS) was used to measure the effectiveness of both peels

Secondary Outcome Measures

Full Information

First Posted
January 18, 2023
Last Updated
January 26, 2023
Sponsor
Combined Military Hospital Abbottabad
search

1. Study Identification

Unique Protocol Identification Number
NCT05712837
Brief Title
Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris
Official Title
Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
November 30, 2022 (Actual)
Study Completion Date
November 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Combined Military Hospital Abbottabad

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
To compare the efficacy of 25% trichloroacetic acid peel versus 30% salicylic acid peel in mild to moderate acne vulgaris. Study Design: Randomized Control Trial. Place And Duration of Study: Department of Dermatology, CMH Abbottabad from 01 Jun 2022 to 30th Nov, 2022. Methodology: A total of 60 patients presented with mild or moderate acne vulgaris were randomized into two groups comprising 30 patients in each group and treated with either the TCA peel or the SA peel at 2-week intervals for 12 weeks. Patients in Group A were treated with 25% TCA peel whereas patients in Group B were treated with 30% SA peel. At the end of therapy after 12 weeks, evaluation of active acne was done by individual lesion counts (comedones, papules and pustules) and calculation of the Michaelsson acne score (MAS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acne Vulgaris

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A 25% TCA
Arm Type
Active Comparator
Arm Description
25% TCA peel Patients of group A were treated with 25% TCA peel and patients at 2-week intervals for a total of 12 weeks. Clinical evaluation was done at the end of therapy after 12-weeks of treatment.
Arm Title
Group B 30% SALICYLIC ACID
Arm Type
Active Comparator
Arm Description
30% SA peels Patients of group B were treated with 30 % salicylic acid peel and patients at 2 weeks interval for a total of 12 weeks.clinical evaluation was done at the end of therapy after 12 weeks of treatment
Intervention Type
Drug
Intervention Name(s)
25% TRICHLOROACETIC ACID
Other Intervention Name(s)
Peeling agent
Intervention Description
Patients of group A were treated with 25% TCA peel and patients at 2-week intervals for a total of 12 weeks. Clinical evaluation was done at the end of therapy after 12-weeks of treatment.
Intervention Type
Drug
Intervention Name(s)
30% salicylic acid
Other Intervention Name(s)
Peeling agent
Intervention Description
Patients of group B were treated with 30 % salicylic acid peel and patients at 2 weeks interval for a total of 12 weeks.clinical evaluation was done at the end of therapy after 12 weeks of treatment
Primary Outcome Measure Information:
Title
Effectiveness of 25 % trichloroacetic acid peel versus 30 % salicylic acid peel in the treatment of mild to moderate acne vulgaris
Description
Michaelson acne scores (MAS) Michaelson acne scores (MAS) was used to measure the effectiveness of both peels
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients with mild or moderate facial acne vulgaris presented in dermatology opd Exclusion Criteria: Patients with grade III or IV acne vulgaris patients taking any acne medications or had taken oral or topical medications in the past 4 weeks pregnant female patients or nursing a baby patients with known hypersensitivity to the formulations used in the study or a history of photosensitivity hypertrophic scars, keloidal tendency, active or recurrent herpes simplex infection active dermatosis unrealistic expectations
Facility Information:
Facility Name
Cmh abbottabad
City
Abbottābād
State/Province
Kpk
ZIP/Postal Code
22010
Country
Pakistan

12. IPD Sharing Statement

Learn more about this trial

Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris

We'll reach out to this number within 24 hrs